Guidelines for presymptomatic testing for Huntington's disease: past, present and future in France.

Clément S, Gargiulo M, Feingold J, Durr A.

Rev Neurol (Paris). 2015 Jun-Jul;171(6-7):572-80. doi: 10.1016/j.neurol.2015.02.016. Review.

Epigenetic dysregulation of hairy and enhancer of split 4 (HES4) is associated with striatal degeneration in postmortem Huntington brains.

Bai G, Cheung I, Shulha HP, Coelho JE, Li P, Dong X, Jakovcevski M, Wang Y, Grigorenko A, Jiang Y, Hoss A, Patel K, Zheng M, Rogaev E, Myers RH, Weng Z, Akbarian S, Chen JF.

Hum Mol Genet. 2015 Mar 1;24(5):1441-56. doi: 10.1093/hmg/ddu561.

Globus pallidus interna deep brain stimulation for chorea-acanthocytosis.

Lee JH, Cho WH, Cha SH, Kang DW.

J Korean Neurosurg Soc. 2015 Feb;57(2):143-6. doi: 10.3340/jkns.2015.57.2.143.

Identification of elevated urea as a severe, ubiquitous metabolic defect in the brain of patients with Huntington's disease.

Patassini S, Begley P, Reid SJ, Xu J, Church SJ, Curtis M, Dragunow M, Waldvogel HJ, Unwin RD, Snell RG, Faull RL, Cooper GJ.

Biochem Biophys Res Commun. 2015 Dec 4-11;468(1-2):161-6. doi: 10.1016/j.bbrc.2015.10.140.

Sydenham's chorea: not gone but perhaps forgotten.

Crealey M, Allen NM, Webb D, Bouldin A, Mc Sweeney N, Peake D, Tirupathi S, Butler K, King MD.

Arch Dis Child. 2015 Dec;100(12):1160-2. doi: 10.1136/archdischild-2015-308693.

Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway.

Szlachcic WJ, Switonski PM, Krzyzosiak WJ, Figlerowicz M, Figiel M.

Dis Model Mech. 2015 Sep;8(9):1047-57. doi: 10.1242/dmm.019406.

Preserving cortico-striatal function: deep brain stimulation in Huntington's disease.

Nagel SJ, Machado AG, Gale JT, Lobel DA, Pandya M.

Front Syst Neurosci. 2015 Mar 11;9:32. doi: 10.3389/fnsys.2015.00032.

Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington's disease.

McColgan P, Seunarine KK, Razi A, Cole JH, Gregory S, Durr A, Roos RA, Stout JC, Landwehrmeyer B, Scahill RI, Clark CA, Rees G, Tabrizi SJ; Track-HD Investigators..

Brain. 2015 Nov;138(Pt 11):3327-44. doi: 10.1093/brain/awv259.

The unfolded protein response and its potential role in Huntington's disease elucidated by a systems biology approach.

Kalathur RK, Giner-Lamia J, Machado S, Barata T, Ayasolla KR, Futschik ME.

Version 2. F1000Res. 2015 May 1 [revised 2016 Jan 1];4:103. doi: 10.12688/f1000research.6358.2.

MicroRNA-124 slows down the progression of Huntington's disease by promoting neurogenesis in the striatum.

Liu T, Im W, Mook-Jung I, Kim M.

Neural Regen Res. 2015 May;10(5):786-91. doi: 10.4103/1673-5374.156978.

Huntington's disease: looking beyond the movement disorder.

Morreale MK.

Adv Psychosom Med. 2015;34:135-42. doi: 10.1159/000369111. Review.

Huntington's disease: an update of therapeutic strategies.

Kumar A, Kumar Singh S, Kumar V, Kumar D, Agarwal S, Rana MK.

Gene. 2015 Feb 10;556(2):91-7. doi: 10.1016/j.gene.2014.11.022. Review.

Altered sensory experience exacerbates stable dendritic spine and synapse loss in a mouse model of Huntington's disease.

Murmu RP, Li W, Szepesi Z, Li JY.

J Neurosci. 2015 Jan 7;35(1):287-98. doi: 10.1523/JNEUROSCI.0244-14.2015.

The effects of physiotherapy with PNF concept on gait and balance of patients with Huntington's disease - pilot study.

Mirek E, Filip M, Banaszkiewicz K, Rudzińska M, Szymura J, Pasiut S, Stożek J, Szczudlik A.

Neurol Neurochir Pol. 2015;49(6):354-7. doi: 10.1016/j.pjnns.2015.09.002.

A new mutation for Huntington disease following maternal transmission of an intermediate allele.

Semaka A, Kay C, Belfroid RD, Bijlsma EK, Losekoot M, van Langen IM, van Maarle MC, Oosterloo M, Hayden MR, van Belzen MJ.

Eur J Med Genet. 2015 Jan;58(1):28-30. doi: 10.1016/j.ejmg.2014.11.005.